Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;32(10):2274-2278.
doi: 10.1038/s41375-018-0078-0. Epub 2018 Feb 27.

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

Ayalew Tefferi  1 , Christy M Finke  2 , Terra L Lasho  2 , Curtis A Hanson  3 , Rhett P Ketterling  4 , Naseema Gangat  2 , Animesh Pardanani  2
Affiliations

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

Ayalew Tefferi et al. Leukemia. 2018 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
U2AF1 mutation types among 491 patients with primary myelofibrosis and comparison of U2AF1 Q157 vs. U2AF1 S34 vs. U2AF1 unmutated categories, in regards to anemia, thrombocytopenia, driver mutational status, and ASXL1 mutations
Fig. 2
Fig. 2
a Survival data on 490 patients with primary myelofibrosis stratified by U2AF1 mutation types. b Survival data on 370 transplant-age patients with primary myelofibrosis (age 70 years or younger), stratified by U2AF1 mutation types
See this image and copyright information in PMC

References

    1. Vannucchi AM, Lasho TL, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, et al. Mutations and prognosis in primary myelofibrosis. Leukemia. 2013;27:1861–9. doi: 10.1038/leu.2013.119. - DOI - PubMed
    1. Tefferi A, Lasho TL, Finke CM, Elala Y, Hanson CA, Ketterling RP, et al. Targeted deep sequencing in primary myelofibrosis. Blood Adv. 2016;1:105–11. doi: 10.1182/bloodadvances.2016000208. - DOI - PMC - PubMed
    1. Lasho TL, Finke CM, Hanson CA, Jimma T, Knudson RA, Ketterling RP, et al. SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients. Leukemia. 2012;26:1135–7. doi: 10.1038/leu.2011.320. - DOI - PubMed
    1. Barraco D, Elala YC, Lasho TL, Begna KH, Gangat N, Finke C, et al. Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations. Blood Cancer J. 2016;6:e415. doi: 10.1038/bcj.2016.22. - DOI - PMC - PubMed
    1. Li Bing, Liu Jinqin, Jia Yujiao, Wang Jingya, Xu Zefeng, Qin Tiejun, Shi Zhongxun, Song Zhen, Peng Shuailing, Huang Huijun, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Qu Shiqiang, Zhang Yue, Wu Jian, Liu Na, Ru Kun, Huang Gang, Xiao Zhijian. Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes. Genes, Chromosomes and Cancer. 2017;57(2):80–88. doi: 10.1002/gcc.22510. - DOI - PMC - PubMed

LinkOut - more resources